Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
6 holders
Ownership
Activity
Fundamentals
2015 Q4
41 of 52 quarters
Total Value
$527.66M
Total Shares
5.21M
Net Share Change
-1.32M
Activity
1 buying
4 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$434.25M
4.29M
4.5%
TRIM
-1.30M
(-23.2%)
Egerton Capital
$434.25M
4.29M shares
TRIM
-1.30M
(-23.2%)
Miller Value Partners
$58.45M
577.6K
1.6%
ADD
+38.5K
(+7.1%)
Miller Value Partners
$58.45M
577.6K shares
ADD
+38.5K
(+7.1%)
Bridgewater Associates LP
$22.07M
218.1K
0.3%
TRIM
-4.0K
(-1.8%)
Bridgewater Associates LP
$22.07M
218.1K shares
TRIM
-4.0K
(-1.8%)
Matrix Asset Advisors
$12.27M
121.2K
2.4%
TRIM
-50.7K
(-29.5%)
Matrix Asset Advisors
$12.27M
121.2K shares
TRIM
-50.7K
(-29.5%)
Jensen Investment Management
$381.0K
3.8K
0.0%
TRIM
-390
(-9.4%)
Jensen Investment Management
$381.0K
3.8K shares
TRIM
-390
(-9.4%)
Maverick Capital
$237.0K
2.3K
0.0%
Unchanged
Maverick Capital
$237.0K
2.3K shares
Unchanged
GILD — Gilead Sciences, Inc. - FilingSpy